Social Media Sidebar


Please sign up, comment on articles and bring your friends!

Current poll

PlanetTech is asking:

What do you think about our new web site?

Love it, indeed
Really good solution
Same as old one
The old one was better
This is a new option

Quote of the day

When seen through the lens of technology, few resources are truly scarce; they’re mainly inaccessible. 


Peter Diamandis

Why scientists are shocked by the results of the immunotherapy cancer treatment trial

Posted in Science on 18th Feb, 2016 06:11 PM by AlexMuller

In recent years, scientists have been finding new ways to treat cancer outside of the chemotherapy and surgery combination. One technique, called immunotherapy, has showed promising results by reprogramming the patient’s immune system to attack tumors.


Researchers in Seattle tested a version of immunotherapy on patients who had late-stage leukemia and lymphoma that had exhausted other treatment options, some weren’t expected to survive the experiment.


But the researchers were shocked to find that 27 of the 29 leukemia patients, that’s 94 percent of the study participants, went into complete remission and showed no more signs of the disease. Stanley Riddell, one of the researchers behind the trial, presented the unpublished results on Sunday at the annual AAAS meeting in Washington, D.C.
Our blood contains T cells, which are supposed to detect pathogens in the body. In this study, the researchers removed these cells from patient’s blood and tweaked their genes to recognize the cancer cells that would otherwise slip by the immune system.
The resulting T cells, called CAR-T cells because of the special receptors inserted into them, are then put back in the body. Researchers hypothesized that the CAR-T cells would give the patient a long-term immune response, indeed, a few small but promising trials have corroborated it, but in many cases the T cells end up being less effective over time, either because the cells themselves become exhausted or because the cancer cells inhibit detection.
The results of this trial were different. In addition to the stunning results from the leukemia patients, 19 of 30 lymphoma patients responded to the treatment as well, after just a single dose of CAR-T cells. Many of the patients who were not expected to live for more than a few months are still alive now, three years after the trial started. “This is unprecedented in medicine, to be honest, to get response rates in this range in these very advanced patients,” Riddell said, according to the New York Post.
To the researchers, this strengthens the evidence that CAR-T cells (and immunotherapy in general) might be a viable treatment for cancers beyond lymphoma and leukemia.
But the treatment isn’t perfect quite yet. During the trial, seven patients developed cytokine release syndrome, a life-threatening inflammation that results when too many cancer cells are killed at once, and two of the patients died as a result.
While that might be acceptable risk for a last-ditch effort for patients with terminal cancer, such dramatic side effects wouldn’t be acceptable for patients with earlier stage or less lethal cancers, as Ars Technica reports.
The researchers don’t yet know the best dose for the treatment that wouldn’t cause such a strong reaction but would still get rid of the cancer, and they don’t know how long the patients will remain in remission. But they are heartened and encouraged by the results.
The researchers have submitted a draft of their study to a journal and hope that it will be published soon so that they can continue their work with immunotherapy, according to a press release.

Tags: canceroncologyhealthmedicinediseaseimmunotherapybiotechnology

Read original article » Back to category


Author: Guest
Posted: 2016-02-19
Clearly, this a breakthrough in cancer treatments. It remains to be seen how these treatments that involve reprogramming of the immune system can be applied to other types of cancer
1 Replies
Author: Guest
Posted: 2016-02-19
People are exited and not just scientists and doctors, so many think first about some patients that this could help. All hopes are that it will Reply


Recent headlines

  • Posted in Business on 2017-12-14 01:48:06
    World Bank to stop financing oil, gas projects from more
    Posted in Medicine on 2017-12-13 21:23:13
    Marijuana May Help HIV Patients Keep Mental Stamina more
    Posted in Business on 2017-12-12 23:15:37
    DeepMind Proves Its AI System's General more
    Posted in Software on 2017-12-12 23:04:47
    Blockchain's Boom Year: Job Market Grows more
    Posted in Science on 2017-12-12 22:55:41
    President Trump signs directive to return astronauts more
Posted in Business on 2013-10-10 01:33
China is working towards a manned lunar mission in more
Posted in Business on 2013-10-20 07:17
Spacex says China is their main competitor for more
Posted in Software on 2013-10-20 06:43
Pirate Bay Browser Clocks 1,000,000 more
Posted in Medicine on 2013-10-10 02:10
Google reportedly investing hundreds of millions into more
Posted in Medicine on 2013-10-14 03:13
Endothelial Cells Can Repair and Regenerate Organs, more
Posted in Science on 01.01.2010
Spacex says China is their main competitor for more
Posted in Science on 01.01.2010
Staring at Your Phone Could Be Making You Short more
Posted in Science on 01.01.2010
Oculus Rift virtual reality headset coming to mobile, more
Posted in Science on 01.01.2010
China is working towards a manned lunar mission in more
Posted in Science on 01.01.2010
Delivering drugs via nanoparticles to target more

Recent Blog Posts

  • Posted by AlexMuller
    Martian landscapes formed from sand 'levitating' on a more
    Posted by AlexMuller
    Scientists detect comets outside our solar more
    Posted by AlexMuller
    Advanced artificial limbs mapped in the more
    Posted by AlexMuller
    Bacteria have a sense of more
    Posted by AlexMuller
    Recurrent brain cancer: New hope with phase 1 clinical more

Login to your Account

Login to your PlanetTech Account here

Remember me

Create a New Account

You just need username and password

The following errors occured:
Verify password:
Remember me